A Randomized Phase 3 Study Assessing the Efficacy and Safety of Olvi-Vec Followed by Platinum-doublet Chemotherapy and Bevacizumab Compared With Physician's Choice of Chemotherapy and Bevacizumab in Women With Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT05281471

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:28:11.977383+00:00

Published At

2026-03-18T00:00:00+00:00

Record Updated At

2026-03-18

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Platinum-resistant Ovarian Cancer", "Platinum-refractory Ovarian Cancer", "Fallopian Tube Cancer", "Primary Peritoneal Cancer", "High-grade Serous Ovarian Cancer", "Endometrioid Ovarian Cancer", "Ovarian Clear Cell Carcinoma"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-03-18"

protocolSection.identificationModule.nctId

"NCT05281471"

protocolSection.identificationModule.officialTitle

"A Randomized Phase 3 Study Assessing the Efficacy and Safety of Olvi-Vec Followed by Platinum-doublet Chemotherapy and Bevacizumab Compared With Physician\u0027s Choice of Chemotherapy and Bevacizumab in Women With Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Platinum-resistant Ovarian Cancer (protocolSection.conditionsModule.conditions)
• Platinum-refractory Ovarian Cancer (protocolSection.conditionsModule.conditions)
• Fallopian Tube Cancer (protocolSection.conditionsModule.conditions)
• Primary Peritoneal Cancer (protocolSection.conditionsModule.conditions)
• High-grade Serous Ovarian Cancer (protocolSection.conditionsModule.conditions)
• Endometrioid Ovarian Cancer (protocolSection.conditionsModule.conditions)
• Ovarian Clear Cell Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.